The Enterprise Value as of November 2025 (TTM) for Living Cell Technologies Limited (LVCLY) is 21.43M

According to Living Cell Technologies Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 21.43M. This represents a change of 14.10% compared to the average of 18.78M of the last 4 quarters.

Living Cell Technologies Limited (LVCLY) Historical Enterprise Value (quarterly & annually)

How has LVCLY Enterprise Value performed in the past?

The mean historical Enterprise Value of Living Cell Technologies Limited over the last ten years is 17.12M. The current 21.43M Enterprise Value has changed 12.42% with respect to the historical average. Over the past ten years (40 quarters), LVCLY's Enterprise Value was at its highest in in the June 2010 quarter at 57.47M. The Enterprise Value was at its lowest in in the December 2021 quarter at -656740.69.

Living Cell Technologies Limited (LVCLY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Living Cell Technologies Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Living Cell Technologies Limited (LVCLY) Average Enterprise Value

How has LVCLY Enterprise Value performed in the past?

The current Enterprise Value of Living Cell Technologies Limited (LVCLY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Living Cell Technologies Limited (LVCLY) Enterprise Value vs. Peers

How is LVCLY’s Enterprise Value compared to its peers?

Living Cell Technologies Limited’s Enterprise Value is greater than Avecho Biotechnology Limited (17.86M), greater than Ceapro Inc. (-5906285.00), less than Eiger BioPharmaceuticals, Inc. (28.35M), less than Poxel S.A. (57.07M), greater than Bionomics Limited (-5622531.00), less than Rapid Dose Therapeutics Corp. (26.58M), greater than Antibe Therapeutics Inc. (8.88M), greater than LexaGene Holdings Inc. (7.86M), greater than Verici Dx plc (12.99M), less than Noxopharm Limited (28.10M),

Build a custom stock screener for Living Cell Technologies Limited (LVCLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Living Cell Technologies Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Living Cell Technologies Limited (LVCLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Living Cell Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.